Literature DB >> 11840291

Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line.

S P Srinivasa1, P D Doshi.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) and fetal liver tyrosine kinase-3 (Flt3) ligand (FL) act in synergy to induce expansion and mobilization of hematopoietic progenitor cells. Regulation of mitogen activated protein (MAP) kinase pathways and gene transcription, induced by these cytokines were examined using the OCI-AML5 cell line. For this purpose, FL and G-CSF were used either alone, or in combination as the co-addition of FL and G-CSF (FL+G-CSF), or a chimeric molecule, progenipoietin-1 (ProGP-1). Both G-CSF and FL induced phosphorylation of extracellular signal-regulated kinases (ERKs) while p38 mitogen activated protein (MAP) kinase was phosphorylated only in response to G-CSF but not FL. Studies using specific kinase inhibitors suggested that both ERK and p38 MAP kinase pathways were required for the optimal cell proliferation in response to both G-CSF and FL. The magnitude of activation of the ERK pathway and induction of genes involved in cell cycle progression by G-CSF and FL exhibited a strong correlation with the degree of cell proliferation. These data suggest that OCI-AML5 cells proliferate at least in part, due to the activation of both ERK and p38 MAP kinase pathways in response to G-CSF and FL. This study represents the first report of the specific cell cycle genes induced by FL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840291     DOI: 10.1038/sj.leu.2402367

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  10 in total

1.  Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells.

Authors:  Zhao Xiaoxia; Ni Weihua; Zhang Qingyong; Wang Fengli; Li Yingying; Sun Xiaxia; Liu Zhonghui; Tai Guixiang
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

Review 2.  Cytokine-mediated communication: a quantitative appraisal of immune complexity.

Authors:  Grégoire Altan-Bonnet; Ratnadeep Mukherjee
Journal:  Nat Rev Immunol       Date:  2019-04       Impact factor: 53.106

3.  A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr.

Authors:  Ivette Perez; Sandra Berndt; Rupesh Agarwal; Manuel A Castro; Sergey A Vishnivetskiy; Jeremy C Smith; Charles R Sanders; Vsevolod V Gurevich; T M Iverson
Journal:  J Mol Biol       Date:  2021-12-11       Impact factor: 5.469

4.  Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).

Authors:  David B Rosen; Mark D Minden; Steven M Kornblau; Aileen Cohen; Urte Gayko; Santosh Putta; John Woronicz; Erik Evensen; Wendy J Fantl; Alessandra Cesano
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

5.  Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disorders.

Authors:  Toshie Ogasawara; Masako Yasuyama; Kiyotaka Kawauchi
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

6.  Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo.

Authors:  Mark C Weir; Sherry T Shu; Ravi K Patel; Sabine Hellwig; Li Chen; Li Tan; Nathanael S Gray; Thomas E Smithgall
Journal:  ACS Chem Biol       Date:  2018-05-30       Impact factor: 5.100

7.  Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Authors:  Craig Dorrell; Katsuto Takenaka; Mark D Minden; Robert G Hawley; John E Dick
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Computer simulations of the signalling network in FLT3 +-acute myeloid leukaemia - indications for an optimal dosage of inhibitors against FLT3 and CDK6.

Authors:  Antoine Buetti-Dinh; Ran Friedman
Journal:  BMC Bioinformatics       Date:  2018-04-24       Impact factor: 3.169

9.  Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

Authors:  Markus Scholz; Sibylle Schirm; Marcus Wetzler; Christoph Engel; Markus Loeffler
Journal:  Theor Biol Med Model       Date:  2012-07-30       Impact factor: 2.432

10.  Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice.

Authors:  N Naganna; Clement Opoku-Temeng; Eun Yong Choi; Elizabeth Larocque; Elizabeth T Chang; Brandon A Carter-Cooper; Modi Wang; Sandra E Torregrosa-Allen; Bennett D Elzey; Rena G Lapidus; Herman O Sintim
Journal:  EBioMedicine       Date:  2019-01-25       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.